Article | April 10, 2019

Controlling Complexity (Not Cost) Of Advanced Therapy Supply Chains

Source: Thermo Fisher Scientific
Controlling Complexity (Not Cost) of Advanced Therapy Supply Chains

Due to the short shelf life and clinical criticality of advanced therapies, their supply chains are often highly complex.  Once efficacy and safety is demonstrated, the focus of advanced therapy developers moves to controlling cost.  However, the biggest cost within the supply chain is caused by its complexity.  In this article, we will share why the advanced therapy supply chain is so complex and how this complexity correlates to cost.